Evidence map›Paper›PMID 42876542›Full record

ArticleFrontiers in microbiology2026

Gut microbiome resistotypes reflect chronological age and

Elizaveta V Starikova, Polina A Kuzmichenko, Dmitry E Fedorov, Andrey V Vvedensky, Alexander V Pavlenko, Anna L Arkhipova, Svetlana N Kovalchuk, Elena N Ilina

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elizaveta V StarikovaMartsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov University, Moscow, Russia.
Polina A KuzmichenkoResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.
Dmitry E FedorovResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.
Andrey V VvedenskyResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.
Alexander V PavlenkoResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.
Anna L ArkhipovaResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.
Svetlana N KovalchukResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.
Elena N IlinaResearch Institute of Systems Biology and Medicine (RISBM), Moscow, Russia.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: Surveillance of antibiotic resistance genes (ARGs) in the human gut microbiota is critical for informing public health interventions and antibiotic stewardship strategies, taking into account sociodemographic, behavioral, and health-related factors. Although metagenomics research has grown exponentially, few studies have described resistome dynamics over time. In this study, we investigated resistome profiles over a 5-year interval (between 2016-2017 and 2022) in adult residents of Arkhangelsk, Northwestern Russia. Results: Over 5 years, we observed an increase in ARGs richness and abundance along with the prevalence changes in genes conferring resistance to aminoglycosides ( Conclusions: We showed an increase in overall ARG richness, ARG abundance, and the prevalence of certain ARGs in microbiomes of adult residents of Arkhangelsk over a 5-year period. We have identified two resistotypes; the one with higher ARGs richness was linked to higher chronological age and

Indexed as

agingantibiotic resistanceCOVID-19resistomeresistotypes

Identifiers

PMID42876542
PMCPMC13661311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.